Best Tricyclic Antidepressant for Patients with Chronic Kidney Disease

Medication Management in CKD

Comprehensive medication management is essential in CKD patients due to pharmacokinetic and pharmacodynamic alterations that occur with declining kidney function, according to Kidney International 1, 2
Individualized pharmacotherapy in CKD should consider dose adjustments, dialysis clearance, and therapeutic drug monitoring to optimize outcomes, as recommended by Kidney International 1
When selecting medications for CKD patients, clinicians should prioritize drugs that do not require significant dose adjustments to minimize risk of adverse effects, as suggested by Kidney International 1, 2

Regular monitoring of serum creatinine and potassium levels is recommended when using medications in CKD patients, particularly those that affect the renin-angiotensin system, according to Diabetes Care 3

Avoid combining TCAs with other medications that may worsen kidney function, such as NSAIDs, which should be avoided in patients with CKD, as advised by the guideline society 4

Avoid prescribing TCAs with active metabolites that increase hypoglycemia risk in reduced kidney function, as cautioned by the guideline society 5
Do not combine TCAs with other medications that may further impair renal function, such as the triple combination of NSAIDs, diuretics, and ACE inhibitors or ARBs, as warned by the guideline society 4